サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1706773

外来輸液センター市場：世界の産業分析、規模、シェア、成長、動向、予測、2025-2035年

Ambulatory Infusion Centers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 213 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
外来輸液センター市場：世界の産業分析、規模、シェア、成長、動向、予測、2025-2035年
出版日: 2025年02月21日
発行: Transparency Market Research
ページ情報: 英文 213 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

外来輸液センター市場- 調査範囲

TMRの調査レポート「世界の外来輸液センター市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の外来輸液センター市場の収益と予測を提供します。また、2025年から2035年までの世界の外来輸液センター市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、外来輸液センター市場を推察しました。

市場スナップショット
2024年の市場規模 203億米ドル
2035年の市場規模 523億米ドル
CAGR 8.9%

本レポートでは、世界の外来輸液センター市場の競合情勢について掘り下げています。世界の外来輸液センター市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の外来輸液センター市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の外来輸液センター市場の市場分析と予測, 2020-2035年

第5章 主要洞察

  • 主要な業界イベント
  • PESTEL分析
  • 主要国・地域別の規制シナリオ
  • ポーターのファイブフォース分析
  • 技術的進歩
  • 市場のアンメットニーズ
  • 国別のヘルスケア費支出

第6章 世界の市場分析と予測：センター種別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：センター種別, 2020-2035年
    • 病院併設の輸液センター
    • 医師主導型輸液センター
    • 独立輸液センター
  • 市場の魅力分析：センター種別

第7章 世界の市場分析と予測：治療の種類別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：治療の種類別, 2020-2035年
    • 抗生物質
    • 血液製品
    • 栄養製品
    • 免疫抑制剤
    • 免疫刺激剤
    • モノクローナル抗体
    • 免疫グロブリン療法
    • その他
  • 市場の魅力分析：治療の種類別

第8章 世界の市場分析と予測：疾患別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：疾患別, 2020-2035年
    • 腫瘍学
    • 呼吸器科
    • 神経学
    • 胃腸
    • 免疫学
    • 心臓病学
    • その他
  • 市場の魅力分析：疾患別

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別, 2020-2035年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第10章 北米の市場分析と予測

第11章 欧州の市場分析と予測

第12章 アジア太平洋地域の市場分析と予測

第13章 ラテンアメリカの市場分析と予測

第14章 中東・アフリカの市場分析と予測

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • Flexcare Infusion Centers
    • Hawaii Medical Service Association
    • Pure Infusion Suites
    • National Infusion Center Association
    • TwelveStone Health Partners
    • Richmond University Medical Center
    • CitusHealth
    • Valley Health System
    • Cedars-Sinai
    • Arnot Health
    • PharmaScript
    • Naval Medical Center Portsmouth
    • Cheyenne Regional Medical Center
    • Pacific Medical Centers
    • ChristianaCare
図表

List of Tables

  • Table 01: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 02: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 03: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 04: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 07: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 08: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 09: Europe - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 11: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 12: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 13: Asia Pacific - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 15: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 16: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 17: Latin America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 19: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 20: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
  • Table 21: Middle East & Africa - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
  • Table 23: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
  • Table 24: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035

List of Figures

  • Figure 01: Global Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 02: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 03: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Hospital-based Infusion Centers, 2020-2035
  • Figure 04: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Physician-based Infusion Centers, 2020-2035
  • Figure 05: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Independent Infusion Centers, 2020-2035
  • Figure 06: Global Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
  • Figure 07: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Therapy Type, 2025-2035
  • Figure 08: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Antibiotics, 2020-2035
  • Figure 09: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Blood Products, 2020-2035
  • Figure 10: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Nutritional Products, 2020-2035
  • Figure 11: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunosuppressants, 2020-2035
  • Figure 12: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunostimulants, 2020-2035
  • Figure 13: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Monoclonal antibodies, 2020-2035
  • Figure 14: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunoglobulin Therapy, 2020-2035
  • Figure 15: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 16: Global Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 17: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 18: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Oncology, 2020-2035
  • Figure 19: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Pulmonology, 2020-2035
  • Figure 20: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Neurology, 2020-2035
  • Figure 21: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Gastrointestinal, 2020-2035
  • Figure 22: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunology, 2020-2035
  • Figure 23: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Cardiology, 2020-2035
  • Figure 24: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 25: Global Ambulatory Infusion Centers Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 26: Global Ambulatory Infusion Centers Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 27: North America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 28: North America - Ambulatory Infusion Centers Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 29: North America - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 30: North America Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 31: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 32: North America Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
  • Figure 33: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Therapy Type, 2025-2035
  • Figure 34: North America Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 35: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 36: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 37: Europe - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 38: Europe - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 39: Europe Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 40: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 41: Europe Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
  • Figure 42: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
  • Figure 43: Europe Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 44: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 45: Asia Pacific - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 46: Asia Pacific - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 47: Asia Pacific - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 48: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 49: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 50: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
  • Figure 51: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
  • Figure 52: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 53: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 54: Latin America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 55: Latin America - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 56: Latin America - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 57: Latin America Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 58: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 59: Latin America Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
  • Figure 60: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
  • Figure 61: Latin America Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 62: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
  • Figure 63: Middle East & Africa - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 64: Middle East & Africa - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 65: Middle East & Africa - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 66: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
  • Figure 67: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
  • Figure 68: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
  • Figure 69: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
  • Figure 70: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
  • Figure 71: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
目次
Product Code: TMRGL86470

Ambulatory Infusion Centers Market - Scope of Report

TMR's report on the global ambulatory infusion centers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global ambulatory infusion centers market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ambulatory infusion centers market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ambulatory infusion centers market.

Market Snapshot
Market Value in 2024US$ 20.3 Bn
Market Value in 2035US$ 52.3 Bn
CAGR8.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global ambulatory infusion centers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global ambulatory infusion centers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global ambulatory infusion centers market.

The report delves into the competitive landscape of the global ambulatory infusion centers market. Key players operating in the global ambulatory infusion centers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global ambulatory infusion centers market profiled in this report.

Key Questions Answered in Global ambulatory infusion centers Market Report:

  • What is the sales/revenue generated by ambulatory infusion centers across all regions during the forecast period?
  • What are the opportunities in the global ambulatory infusion centers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Ambulatory Infusion Centers Market - Research Objectives and Research Approach

The comprehensive report on the global ambulatory infusion centers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global ambulatory infusion centers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global ambulatory infusion centers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ambulatory Infusion Centers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Ambulatory Infusion Centers Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. PESTEL Analysis
  • 5.3. Regulatory Scenario by Key Countries/Region
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. Technological Advancements
  • 5.6. Unmet Needs of the Market
  • 5.7. Healthcare Spending's by Country

6. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Type of Center

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type of Center, 2020-2035
    • 6.3.1. Hospital-based Infusion Centers
    • 6.3.2. Physician-based Infusion Centers
    • 6.3.3. Independent Infusion Centers
  • 6.4. Market Attractiveness Analysis, by Type of Center

7. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Therapy Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 7.3.1. Antibiotics
    • 7.3.2. Blood Products
    • 7.3.3. Nutritional Products
    • 7.3.4. Immunosuppressants
    • 7.3.5. Immunostimulants
    • 7.3.6. Monoclonal Antibodies
    • 7.3.7. Immunoglobulin Therapy
    • 7.3.8. Others
  • 7.4. Market Attractiveness Analysis, by Therapy Type

8. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Disease Specialties

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Disease Specialties, 2020-2035
    • 8.3.1. Oncology
    • 8.3.2. Pulmonology
    • 8.3.3. Neurology
    • 8.3.4. Gastrointestinal
    • 8.3.5. Immunology
    • 8.3.6. Cardiology
    • 8.3.7. Others
  • 8.4. Market Attractiveness Analysis, by Disease Specialties

9. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Ambulatory Infusion Centers Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type of Center, 2020-2035
    • 10.2.1. Hospital-based Infusion Centers
    • 10.2.2. Physician-based Infusion Centers
    • 10.2.3. Independent Infusion Centers
  • 10.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 10.3.1. Antibiotics
    • 10.3.2. Blood Products
    • 10.3.3. Nutritional Products
    • 10.3.4. Immunosuppressants
    • 10.3.5. Immunostimulants
    • 10.3.6. Monoclonal Antibodies
    • 10.3.7. Immunoglobulin Therapy
    • 10.3.8. Others
  • 10.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 10.4.1. Oncology
    • 10.4.2. Pulmonology
    • 10.4.3. Neurology
    • 10.4.4. Gastrointestinal
    • 10.4.5. Immunology
    • 10.4.6. Cardiology
    • 10.4.7. Others
  • 10.5. Market Value Forecast, by Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type of Center
    • 10.6.2. By Therapy Type
    • 10.6.3. By Disease Specialties
    • 10.6.4. By Country

11. Europe Ambulatory Infusion Centers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type of Center, 2020-2035
    • 11.2.1. Hospital-based Infusion Centers
    • 11.2.2. Physician-based Infusion Centers
    • 11.2.3. Independent Infusion Centers
  • 11.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 11.3.1. Antibiotics
    • 11.3.2. Blood Products
    • 11.3.3. Nutritional Products
    • 11.3.4. Immunosuppressants
    • 11.3.5. Immunostimulants
    • 11.3.6. Monoclonal Antibodies
    • 11.3.7. Immunoglobulin Therapy
    • 11.3.8. Others
  • 11.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 11.4.1. Oncology
    • 11.4.2. Pulmonology
    • 11.4.3. Neurology
    • 11.4.4. Gastrointestinal
    • 11.4.5. Immunology
    • 11.4.6. Cardiology
    • 11.4.7. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type of Center
    • 11.6.2. By Therapy Type
    • 11.6.3. By Disease Specialties
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Ambulatory Infusion Centers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type of Center, 2020-2035
    • 12.2.1. Hospital-based Infusion Centers
    • 12.2.2. Physician-based Infusion Centers
    • 12.2.3. Independent Infusion Centers
  • 12.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 12.3.1. Antibiotics
    • 12.3.2. Blood Products
    • 12.3.3. Nutritional Products
    • 12.3.4. Immunosuppressants
    • 12.3.5. Immunostimulants
    • 12.3.6. Monoclonal Antibodies
    • 12.3.7. Immunoglobulin Therapy
    • 12.3.8. Others
  • 12.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 12.4.1. Oncology
    • 12.4.2. Pulmonology
    • 12.4.3. Neurology
    • 12.4.4. Gastrointestinal
    • 12.4.5. Immunology
    • 12.4.6. Cardiology
    • 12.4.7. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type of Center
    • 12.6.2. By Therapy Type
    • 12.6.3. By Disease Specialties
    • 12.6.4. By Country/Sub-region

13. Latin America Ambulatory Infusion Centers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type of Center, 2020-2035
    • 13.2.1. Hospital-based Infusion Centers
    • 13.2.2. Physician-based Infusion Centers
    • 13.2.3. Independent Infusion Centers
  • 13.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 13.3.1. Antibiotics
    • 13.3.2. Blood Products
    • 13.3.3. Nutritional Products
    • 13.3.4. Immunosuppressants
    • 13.3.5. Immunostimulants
    • 13.3.6. Monoclonal Antibodies
    • 13.3.7. Immunoglobulin Therapy
    • 13.3.8. Others
  • 13.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 13.4.1. Oncology
    • 13.4.2. Pulmonology
    • 13.4.3. Neurology
    • 13.4.4. Gastrointestinal
    • 13.4.5. Immunology
    • 13.4.6. Cardiology
    • 13.4.7. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type of Center
    • 13.6.2. By Therapy Type
    • 13.6.3. By Disease Specialties
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Ambulatory Infusion Centers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type of Center, 2020-2035
    • 14.2.1. Hospital-based Infusion Centers
    • 14.2.2. Physician-based Infusion Centers
    • 14.2.3. Independent Infusion Centers
  • 14.3. Market Value Forecast, by Therapy Type, 2020-2035
    • 14.3.1. Antibiotics
    • 14.3.2. Blood Products
    • 14.3.3. Nutritional Products
    • 14.3.4. Immunosuppressants
    • 14.3.5. Immunostimulants
    • 14.3.6. Monoclonal Antibodies
    • 14.3.7. Immunoglobulin Therapy
    • 14.3.8. Others
  • 14.4. Market Value Forecast, by Disease Specialties, 2020-2035
    • 14.4.1. Oncology
    • 14.4.2. Pulmonology
    • 14.4.3. Neurology
    • 14.4.4. Gastrointestinal
    • 14.4.5. Immunology
    • 14.4.6. Cardiology
    • 14.4.7. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type of Center
    • 14.6.2. By Therapy Type
    • 14.6.3. By Disease Specialties
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Flexcare Infusion Centers
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Hawaii Medical Service Association
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Pure Infusion Suites
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. National Infusion Center Association
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. TwelveStone Health Partners
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Richmond University Medical Center
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. CitusHealth
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Valley Health System
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Cedars-Sinai
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Arnot Health
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. PharmaScript
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Naval Medical Center Portsmouth
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Cheyenne Regional Medical Center
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Pacific Medical Centers
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. ChristianaCare
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Product Portfolio
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments